Showing 49 to 60 of 118 results


Cardiovascular Disease: US Deaths Exceed Cancer and Dementia Combined
In 2022, cardiovascular disease caused nearly 1 million deaths in the US, surpassing cancer and dementia combined; rising risk factors like obesity and high blood pressure contribute to this alarming statistic, with projections indicating a worsening crisis unless preventative measures are taken.
Cardiovascular Disease: US Deaths Exceed Cancer and Dementia Combined
In 2022, cardiovascular disease caused nearly 1 million deaths in the US, surpassing cancer and dementia combined; rising risk factors like obesity and high blood pressure contribute to this alarming statistic, with projections indicating a worsening crisis unless preventative measures are taken.
Progress
36% Bias Score


Kennedy's HHS Nomination Hearing Highlights Urgent US Health Crisis
Robert F. Kennedy Jr.'s upcoming confirmation hearing for HHS Secretary on January 29th centers on his "Make America Healthy Again" movement, aiming to combat the U.S.'s health crisis through improved nutrition and reduced environmental toxins, as supported by Fox News medical analyst Dr. Marc Siege...
Kennedy's HHS Nomination Hearing Highlights Urgent US Health Crisis
Robert F. Kennedy Jr.'s upcoming confirmation hearing for HHS Secretary on January 29th centers on his "Make America Healthy Again" movement, aiming to combat the U.S.'s health crisis through improved nutrition and reduced environmental toxins, as supported by Fox News medical analyst Dr. Marc Siege...
Progress
56% Bias Score


Kennedy-Oz Clash on Weight-Loss Drug Coverage Looms
The conflicting views of Robert F. Kennedy Jr. and Mehmet Oz on the Trump administration's policy regarding Medicare and Medicaid coverage of costly new weight-loss drugs create uncertainty, impacting millions' access to potentially life-changing medication.
Kennedy-Oz Clash on Weight-Loss Drug Coverage Looms
The conflicting views of Robert F. Kennedy Jr. and Mehmet Oz on the Trump administration's policy regarding Medicare and Medicaid coverage of costly new weight-loss drugs create uncertainty, impacting millions' access to potentially life-changing medication.
Progress
44% Bias Score


NPA warns of weight-loss jab safety risks from online sales
The National Pharmacy Association (NPA) warns of patient safety risks from online sales of weight-loss jabs, urging for stricter regulations and mandatory 20-minute consultations to prevent misuse, particularly in individuals with eating disorders or low body weight. Hundreds of thousands use online...
NPA warns of weight-loss jab safety risks from online sales
The National Pharmacy Association (NPA) warns of patient safety risks from online sales of weight-loss jabs, urging for stricter regulations and mandatory 20-minute consultations to prevent misuse, particularly in individuals with eating disorders or low body weight. Hundreds of thousands use online...
Progress
36% Bias Score


GLP-1 Drugs Show Significant Health Benefits and Risks in Large-Scale Study
A study of over two million veterans found that GLP-1 drugs, such as Ozempic, significantly reduce risks of neurocognitive disorders, addiction, and self-harm, but also increase the risk of pancreatic and kidney problems.
GLP-1 Drugs Show Significant Health Benefits and Risks in Large-Scale Study
A study of over two million veterans found that GLP-1 drugs, such as Ozempic, significantly reduce risks of neurocognitive disorders, addiction, and self-harm, but also increase the risk of pancreatic and kidney problems.
Progress
52% Bias Score


GLP-1 Weight-Loss Drugs: Significant Health Benefits and Risks Revealed
A study of over 2.4 million people found that GLP-1 weight-loss medications reduced the risk of 42 health conditions, including cardiac arrest and Alzheimer's disease, by reducing inflammation and improving impulse control, but increased risks of gastrointestinal issues were also observed.
GLP-1 Weight-Loss Drugs: Significant Health Benefits and Risks Revealed
A study of over 2.4 million people found that GLP-1 weight-loss medications reduced the risk of 42 health conditions, including cardiac arrest and Alzheimer's disease, by reducing inflammation and improving impulse control, but increased risks of gastrointestinal issues were also observed.
Progress
36% Bias Score

Obesity Crisis and the "Make America Healthy Again" Initiative
The Affordable Care Act's unintended consequences, coupled with the COVID-19 pandemic, have led to soaring obesity rates in America, increasing healthcare costs. The "Make America Healthy Again" initiative, spearheaded by Robert F. Kennedy Jr., aims to combat this by promoting healthier lifestyles a...

Obesity Crisis and the "Make America Healthy Again" Initiative
The Affordable Care Act's unintended consequences, coupled with the COVID-19 pandemic, have led to soaring obesity rates in America, increasing healthcare costs. The "Make America Healthy Again" initiative, spearheaded by Robert F. Kennedy Jr., aims to combat this by promoting healthier lifestyles a...
Progress
68% Bias Score

Fat Cell Memory Explains Weight Regain After Dieting
A Nature study reveals that fat cells 'remember' being fat, making weight loss difficult; 90% of dieters regain weight due to epigenetic changes in fat cells that persist even after weight loss, highlighting the need for long-term lifestyle changes for sustainable weight management.

Fat Cell Memory Explains Weight Regain After Dieting
A Nature study reveals that fat cells 'remember' being fat, making weight loss difficult; 90% of dieters regain weight due to epigenetic changes in fat cells that persist even after weight loss, highlighting the need for long-term lifestyle changes for sustainable weight management.
Progress
40% Bias Score

Soaring Demand for Expensive Weight-Loss Drugs in the Netherlands
The number of Dutch citizens purchasing costly new weight-loss drugs increased dramatically from 2000 prescriptions in 2022 to 109,000 in 2023, raising concerns about accessibility and the strain on the healthcare system due to high costs and potential exacerbation of health inequalities.

Soaring Demand for Expensive Weight-Loss Drugs in the Netherlands
The number of Dutch citizens purchasing costly new weight-loss drugs increased dramatically from 2000 prescriptions in 2022 to 109,000 in 2023, raising concerns about accessibility and the strain on the healthcare system due to high costs and potential exacerbation of health inequalities.
Progress
52% Bias Score

Revised Obesity Definition Emphasizes Body Fat Impact, Not Just BMI
A new definition of obesity, published in The Lancet Diabetes & Endocrinology, proposes using BMI as an initial screen, but factors in waist circumference and other measures of body fat to assess how excess fat affects the body, potentially shifting clinical care for 890 million adults worldwide.

Revised Obesity Definition Emphasizes Body Fat Impact, Not Just BMI
A new definition of obesity, published in The Lancet Diabetes & Endocrinology, proposes using BMI as an initial screen, but factors in waist circumference and other measures of body fat to assess how excess fat affects the body, potentially shifting clinical care for 890 million adults worldwide.
Progress
32% Bias Score

Weight-Loss Drugs Show Reduced Alzheimer's Risk, But Increased Gastrointestinal Issues
A study of over two million US diabetic patients found that GLP-1 receptor agonist weight-loss drugs like Wegovy and Ozempic reduced the risk of Alzheimer's by 12%, drug/alcohol dependence, and some blood clotting issues, but increased risks of gastrointestinal problems, low blood pressure, and kidn...

Weight-Loss Drugs Show Reduced Alzheimer's Risk, But Increased Gastrointestinal Issues
A study of over two million US diabetic patients found that GLP-1 receptor agonist weight-loss drugs like Wegovy and Ozempic reduced the risk of Alzheimer's by 12%, drug/alcohol dependence, and some blood clotting issues, but increased risks of gastrointestinal problems, low blood pressure, and kidn...
Progress
32% Bias Score

Weight-Loss Drugs Show Promise in Treating Multiple Diseases, but Risks Remain
A Nature Medicine study shows weight-loss drugs like Wegovy and Ozempic effectively treat various diseases by reducing obesity and inflammation, potentially lowering Alzheimer's risk by 12%, but also carry risks of gastrointestinal issues, hypotension, and kidney problems.

Weight-Loss Drugs Show Promise in Treating Multiple Diseases, but Risks Remain
A Nature Medicine study shows weight-loss drugs like Wegovy and Ozempic effectively treat various diseases by reducing obesity and inflammation, potentially lowering Alzheimer's risk by 12%, but also carry risks of gastrointestinal issues, hypotension, and kidney problems.
Progress
24% Bias Score
Showing 49 to 60 of 118 results